The burgeoning burden of Respiratory syncytial virus among children

Infectious Disorders - Drug Targets

Volumn 12, Issue 2, 2012, Pages 92-97

  Hall, Caroline Breese ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Pediatric respiratory infections; Respiratory syncytial virus epidemiology; Respiratory viral infections

Indexed keywords

MOTAVIZUMAB; PALIVIZUMAB; PLACEBO;

ARTICLE; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE SEVERITY; EMERGENCY WARD; HOSPITAL COST; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; MORTALITY; OUTPATIENT DEPARTMENT; PARAINFLUENZA VIRUS INFECTION; PASSIVE IMMUNIZATION; PREVALENCE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS ISOLATION;

EID: 84860313698     PISSN: 18715265     EISSN: 18755852     Source Type: Journal    
DOI: 10.2174/187152612800100099     Document Type: Article

References (52)

1. Chanock, R.; Parrott, R. Acute respiratory disease in infancy and childhood: Present understanding and prospects for prevention. Pediatrics, 1965, 36, 21-39.
2. Chanock, R.; Roizman, B.; Myers, R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA): I. Isolation, properties and characterization. Am. J. Hyg., 1957, 66, 281-290.
3. Chanock, R. Control of acute mycoplasmal and viral respiratory tract disease. Science, 1970, 169, 248-256.
4. Glezen, W.; Taber, L.; Frank, A.; Kasel, J. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child, 1986, 140, 543-546.
5. Karron, R.; Singleton, R.; Bulkow, L.; Parkinson, A.; Kruse, D.; DeSmet, I.; Inforf, C.; Petersen, K.; Leombruno, D.; Hurlburt, D.; Santosham, M.; Harrison, L. Group, R.A.S. Severe respiratory syncytial virus disease in Alaska native children. J. Infect. Dis., 1999, 180, 41-49.
6. Nielsen, H.; Siersma, V.; Andersen, S.; Gahrn-Hansen, B.; Mordhorst, C.; Norgaard-Pedersen, B.; Roder, B.; Sorensen, T.; Temme, R.; Vestergaard, B. Respiratory syncytial virus infection--risk factors for hospital admission: a case-control study. Acta Paediatr., 2003, 92, 1314-1321.
7. Hall, C.; Weinberg, G.; Iwane, M.; Blumkin, A.; Edwards, K.; Staat, M.; Auinger, P.; Griffin, M.; Poehling, K.; Erdman, D.; Grijalva, C.; Zhu, Y.; Szilagyi, P. The burden of respiratory syncytial virus infection among healthy children. N Engl J Med, 2009, 360, 588-598.
8. Pelletier, A.; Mansbach, J.; Camargo, C.J. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics, 2006, 118, 2418-2423.
9. Shay, D.; Holman, R.; Newman, R.; Liu, L.; Stout, J.; Anderson, L. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA, 1999, 282, 1440-1446.
10. Langley, J.; LeBlanc, J.; Smith, B.; Wang, E. Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000. J. Infec. Dis., 2003, 188, 1764-1767.
11. Paramore, L.; Ciuryla, V.; Ciesla, G.; Liu, L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics, 2004, 22, 275-284.
12. Boyce, T.; Mellen, B.; Mitchel, E.J.; Wright, P.; Griffin, M. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J. Pediatr., 2000, 137, 865-870.
13. Leader, S.; Kohlhase, K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997-1999. Pediatr. Infect. Dis. J., 2002, 21, 629-632.
14. Holman, R.; Curns, A.; Cheek, J.; Bresee, J.; Singleton, R.; Carver, K.; Anderson, L. Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics, 2004, 114, e437-e444.
15. Singleton, R.; Bruden, D.; Bulkow, L. Respiratory syncytial virus season and hospitalizations in the alaskan yukon-kuskokwim delta. Pediatr. Infect. Dis. J., 2007, 26, S46-S50.
16. Banerji, A.; Greenberg, D.; White, L.F.; Macdonald, W.A.; Saxton, A.; Thomas, E.; Sage, D.; Mamdani, M.; Lanctot, K.L.; Mahony, J.B.; Dingle, M.; Roberts, A. Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in Canadian Inuit children: a case-control study. Pediatr. Infect. Dis. J., 2009, 28, 697-701.
17. Iwane, M.; Edwards, K.; Szilagyi, P.; Walker, F.; Griffin, M.; Weinberg, G.; Coulen, C.; Poehling, K.; Shone, L.; Balter, S.; Hall, C.; Erdman, D.; Wooten, K.; Schwartz, B.; Network, N.V.S. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics, 2004, 113, 1758-1764.
18. Eriksson, M.; Bennet, R.; Rotzen-Ostlund, M.; von Sydow, M.; Wirgart, B. Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr., 2002, 91, 593-598.
19. Fjaerli, H.; Farstad, T.; Bratlid, D. Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study. BMC Pediatr., 2004, 25, 1-7.
20. Forster, J.; Ihorst, G.; Rieger, C.; Stephan, V.; Frank, H.; Gurth, H.; Berner, R.; Rohwedder, A.; Werchau, H.; Schumacher, M.; Tsai, T.; Petersen, G. Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI. DE study). Eur. J. Pediatr., 2004, 163, 709-716.
21. Nicholson, K.; McNally, T.; Silverman, M.; Simons, P.; Stockton, J.; Zambon, M. Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children. Vaccine, 2006, 24, 102-108.
22. Weigl, J.; Puppe, W.; Schmitt, H. Incidence of respiratory syncytial virus-positive hospitalizations in Germany. Eur. J. Clin. Microbiol. Infect. Dis., 2001, 20, 452-459.
23. Jansen, A.G.; Sanders, E.A.; Hoes, A.W.; van Loon, A.M.; Hak, E. Influenza-and respiratory syncytial virus-associated mortality and hospitalisations. Eur. Respir. J., 2007, 30, 1158-1166.
24. van Gageldonk-Lafeber, A.B.; Heijnen, M.L.; Bartelds, A.I.; Peters, M.F.; van der Plas, S.M.; Wilbrink, B. A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin. Infect. Dis., 2005, 41, 490-497.
25. Bourgeois, F.; Valim, C.; McAdam, A.; Mandl, K. Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics, 2009, 124, e1072-1080.
26. Mansbach, J.; McAdam, A.; Clark, S.; Hain, P.; Flood, R.; Acholonu, U. Camargo, C., Jr. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad. Emerg. Med., 2008, 15, 111-118.
27. Mansbach, J.; Emond, J.; Camargo, C. Jr. Bronchiolitis in US emergency departments 1992 to 2000: epidemiology and practice variation. Pediatr. Emerg. Care, 2005, 21, 242-247.
28. Nair, H.; Nokes, D.; Gessner, B.; Dherani, M.; Madhi, S.; Singleton, R.; O'Brien, K.; Roca, A.; Wright, P.; Bruce, N.; Chandran, A.; Theodoratou, E.; Sutanto, A.; Sedyaningsih, E.; Ngama, M.; Munywoki, P.; Kartasasmita, C.; Simoes, E.; Rudan, I.; Weber, M.; Campbell, H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet, 2010, 375, 1545-1555.
29. Nokes, D.; Okiro, E.; Ngama, M.; Ochola, R.; White, L.; Scott, P.; English, M.; Cane, P.; Medley, G. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin. Infect. Dis., 2008, 46, 50-57.
30. Weber, M.; Mulholland, E.; Greenwood, B. Respiratory syncytial virus infection in tropical and developing countries. Trop. Med. Int. Health, 1998, 3, 268-280.
31. Madhi, S.; Kuwanda, L.; Cutland, C.; Klugman, K. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children. J. Clin. Virol., 2006, 36, 215-221.
32. McIntosh, K. Pathogenesis of severe acute respiratory infections in the developing world: respiratory syncytial virus and parainfluenza virus. Rev. Infect. Dis., 1991, 13, S492-S500.
33. Law, B.; Carbonell-Estrany, X.; Simoes, E. An update on respiratory syncytial virus epidemiology: a developed country perspective. Resp. Med., 2002, 96, S1-S7.
34. Monto, A. In: Institute of Medicine Committee on Issues and Priorities for New Vaccine Development; Ed.; National Academies Press: Washington, DC, 1986; Vol. 2, pp. 299-308.
35. Howard, T.; Hoffman, L.; Stang, P.; Simoes, E. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality. J. Pediatr., 2000, 137, 227-232.
36. Leader, S.; Kohlhase, K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J. Pediatr., 2003, 143, s127-s132.
37. Thompson, W.; Shay, D.; Weintraub, E.; Brammer, L.; Cox, N.; Anderson, L.; Fukuda, K. Mortality associated with influenza and respiratory syncytial virus in the United States. J. Am. Med. Assoc., 2003, 289, 179-186.
38. Shay, D.; Holman, R.; Roosevelt, G.; Clarke, M.; Anderson, L. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis., 2001, 183, 16-22.
39. Sampalis, J. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J. Pediatr., 2003, 143, S150-S156.
40. Chan, P.; Goh, A. Respiratory syncytial virus infection in young Malaysian children. Sing. Med. J., 1999, 40, 336-340.
41. Howard, T.; Stang, P. The burden of respiratory syncytial virus (RSV) hospitalizations in the US. Value in Health, 2000, 3, 117.
42. Forbes, M.; Hall, C.; Jackson, A.; Masaquel, A.; Mahadevia, P. Comparative costs of hospitalisation among infants at high risk for respiratory syncytial virus lower respiratory tract infection during the first year of life. J. Med. Econ., 2010, 13, 136-141.
43. Palmer, L.; Hall, C.; Katkin, J.; Shi, N.; Masaquel, A.; McLaurin, K.; Mahadevia, P. Healthcare costs within a year of respiratory syncytial virus among medicaid infants. Pediatr. Pulmonol., 2010, 45, 772-781.
44. McLaurin, K.; Hall, C.; Jackson, E.; Owens, O.; Mahadevia, P. Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life. Pediatrics, 2009, 123, 653-659.
45. The Jordan Report: Accelerated Development of Vaccines. 2002. (October 18, 2010, http://www3.niaid.nih.gov/topics/Malaria/PDF/ jordan20_2002.pdf)
46. Connor, E.; Group, T.I.-R.S. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics, 1998, 102, 531-537.
47. Meissner, H.C.; Bocchini, J.A. Jr.; Brady, M.T.; Hall, C.B.; Kimberlin, D.W.; Pickering, L.K. The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus. Pediatrics, 2009, 124, 1676-1679.
48. Hampp, C.; Kauf, T.L.; Saidi, A.S. Winterstein, A.G. Costeffectiveness of Respiratory Syncytial Virus Prophylaxis in Various Indications. Arch. Pediatr. Adolesc Med., 2011, 165(6), 498-505.
49. AAP. From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics, 2009, 124, 1694-1701.
50. Carbonell-Estrany, X.; Simoes, E.; Dagan, R.; Hall, C.; Harris, B.; Hultquist, M.; Connor, E.; Losonsky, G. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics, 2010, 125, e35-51.
51. Graham, B.S. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol. Rev., 2011, 239, 149-166.
52. Roymans, D.; Koul, A. Respiratory syncytial virus: a prioritized or neglected target? Future Med. Chem., 2010, 2, 1523-1527.